Active, not recruitingPhase 1NCT05168423

CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM

Studying Giant cell glioblastoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Pennsylvania
Principal Investigator
Stephen Bagley, MD, MSCE
University of Pennsylvania
Intervention
CART-EGFR-IL13Ra2 Cells(drug)
Enrollment
67 enrolled
Eligibility
18 years · All sexes
Timeline
20232039

Study locations (1)

Collaborators

Kite Pharma (a Gilead Company)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05168423 on ClinicalTrials.gov

Other trials for Giant cell glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Giant cell glioblastoma

← Back to all trials